Axonal Neuropathies

Axonal Neuropathy refers to disease or dysfunction of nerves caused as a result of damage or degeneration of axons. Here is the latest research.

April 17, 2021

Anti-GM1 IgM antibody positive axonal variant of Guillain-Barre-syndrome in a pediatric patient with dengue fever.

Journal of Neuroimmunology
Mario B PradoKaren Joy B Adiao
April 16, 2021
Review

Common Compression Neuropathies.

Clinics in Geriatric Medicine
Svetlana FaktorovichZufe Rizvi
April 16, 2021
Open Access

Acute motor and sensory axonal neuropathy in association with primary Sjögren's syndrome: a case report.

BMC Neurology
Yu-Ming Chen, Kuei-Ying Su
April 15, 2021
Preprint
Open Access

Activation of Sarm1 produces cADPR to increase intra-axonal calcium and promote axon degeneration in CIPN

BioRxiv : the Preprint Server for Biology
Rosa LiRosalind Segal
April 16, 2021
Case Report
Open Access

Association of Guillain-Barre Syndrome With COVID-19: A Case Report and Literature Review.

Curēus
Romil SinghUsama Rehman
April 15, 2021

Homozygous UBA5 Variant Leads to Hypomyelination with Thalamic Involvement and Axonal Neuropathy.

Neuropediatrics
Murtadha L Al-SaadyNicole I Wolf
April 14, 2021

Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child.

Journal of Medical Virology
Nihal AkçayEsra Şevketoğlu
April 12, 2021

A recurrent MORC2 mutation causes CMT2Z.

Journal of the Peripheral Nervous System : JPNS
Dragan VujovicSteven S Scherer
April 11, 2021

Nitrous oxide-induced motor-predominant axonal peripheral neuropathy: A phenotype distinct from isolated vitamin B12 deficiency.

Journal of the Neurological Sciences
Manon LeeNiranjanan Nirmalananthan
April 8, 2021
Open Access

Genetic and clinical spectrums in Korean Charcot-Marie-Tooth disease patients with myelin protein zero mutations.

Molecular Genetics & Genomic Medicine
Hye Jin KimKi Wha Chung
April 10, 2021
Open Access

Determining the Utility of the Guillain-Barré Syndrome Classification Criteria.

Journal of Clinical Neurology
Cheng Yin TanNortina Shahrizaila
April 9, 2021
Review

Connecting TDP-43 Pathology with Neuropathy.

Trends in Neurosciences
Joseph R KlimKevin Eggan
April 9, 2021

Axonal sensorimotor polyneuropathy after starting guselkumab.

The Journal of Dermatological Treatment
Issam Hamadah, Muzamil A Chisti
April 7, 2021
Open Access

High-resolution ultrasound changes of the vagus nerve in idiopathic Parkinson's disease (IPD): a possible additional index of disease.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
F SartucciG Orlandi
April 5, 2021
Open Access

Transplantation of miPSC/mESC-derived retinal ganglion cells into healthy and glaucomatous retinas.

Molecular Therapy. Methods & Clinical Development
Julia OswaldPetr Baranov
April 4, 2021
Open Access

Vocal cord paralysis secondary to vincristine treatment in children - A case series of seven children and literature review.

Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery
Joanna GodbehereRavi Thevasagayam
April 4, 2021
Review

Neurology of inflammatory bowel disease.

Journal of the Neurological Sciences
José M Ferro, Miguel Oliveira Santos
April 2, 2021
Preprint
Open Access

Altered action potential waveform and shorter axonal initial segment in hiPSC-derived motor neurons with mutations in VRK1

BioRxiv : the Preprint Server for Biology
R. BosValerie DELAGUE

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/axonal-neuropathies/090e78de-67fd-4413-9339-1a414fb90d72